Future policy for future precision medicine
| Reference number | |
| Coordinator | RISE Research Institutes of Sweden AB - RISE AB - Digitala System |
| Funding from Vinnova | SEK 999 709 |
| Project duration | April 2025 - June 2026 |
| Status | Completed |
| Venture | Regulation and cutting-edge technology |
| Call | Rules and instruments for cutting-edge technology |
Important results from the project
The project achieved its objectives by identifying and analysing the governance challenges that arise when precision medicine is developed across the boundaries of research, healthcare and industry. The analysis resulted in a new perspective on responsibility in organisational “in between spaces” and the development of the Vägvisaren methodology, a practical tool that makes responsibilities, strategic choices and their consequences visible at an early stage.
Expected long term effects
The project is expected to accelerate the sustainable implementation of precision medicine by strengthening shared responsibility across academia, healthcare and industry. By making responsibilities and risks visible in the early stages of development, local initiatives can more easily evolve into scalable and sustainable practices, thereby enhancing both innovation capacity and patient safety.
Approach and implementation
The project was carried out as a policy lab using an iterative approach that integrated legal, technical and organisational perspectives. Interviews and collaborative exploration involving representatives from academia, healthcare and industry were combined with systems analysis. This approach enabled both a deeper understanding of governance challenges and the development of the practical Vägvisaren methodology.